<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Paris_Bettencourt_Improve skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Paris Bettencourt/Improve</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="col-md-8"><UL class=" text-left wtf-menu "><LI class="parent main-item"><A href="#">Project  </A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Human_Practices">Human Practices</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Applied_Design">Applied Design</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Design">Design</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Production">Production</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Active_Testing">Testing </A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Active_Testing">Active Testing</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Biocompatibility_Testing">Biocompatibility Testing</A></LI></UL><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Model">Modeling</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Optimization">Optimization</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Public_Engagement">Public Engagement</A></LI><LI class="parent main-item"><A href="https://2018.igem.org/Team:Paris_Bettencourt/Software">Software  </A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/AMPDesigner_Overview">AMP Designer Overview</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/AMP_Forest">AMP Forest</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/AMP_Evolver">AMP Evolver</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Result">Result</A></LI><LI class="parent main-item"><A href="#">Judging </A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Medal_Criteria">Medal Criteria </A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Results">Key Results</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/BioBricks">BioBricks</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/InterLab">InterLab</A></LI><LI class="parent main-item"><A href="#">Team  </A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Members">Members</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Collaborations">Collaborations</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Attributions">Attributions</A></LI><LI class="parent main-item"><A href="https://2018.igem.org/Team:Paris_Bettencourt/Lab_Notebook">Lab Notebook</A></LI><LI class="parent main-item"><A href="https://2018.igem.org/Team:Paris_Bettencourt/Acknowledgements">Acknowledgements</A></LI><DIV id="logolist2"><DIV class="sidelogos top5"><DIV id="twitapp"><A class="twitter-timeline" width="250" height="400" data-dnt="true" href="https://twitter.com/iGEM_Paris" data-widget-id="368144501119795201">@iGEM_Paris</A></DIV></DIV></DIV></DIV><DIV class="textbody h1"><H1>BioBricks for Improved Part</H1></DIV><DIV class="textbody h2"><H2>New Part - Part: BBa_K2738006 (Ferritin-ovispirin)</H2></DIV><DIV class="textbody"><P> We aimed to fuse antimicrobial peptides to self-assembling multimeric proteins giving us star-shape antimicrobial peptides called StarCores. The StarCore described here is a result of the fusion of Ferritin (self-assembling protein) to ovispirin (antimicrobial peptide) via golden-gate assembly. The fusion protein expression is regulated by T7-promoter.  </P><P> Ferritin is a universal intracellular protein produced by almost all living organisms, including algae, bacteria, higher plants, and animals. Ferritin is a globular protein complex consisting of 24 protein subunits forming a nanocage. Ovispirin is an alpha-helical antimicrobial peptide derived from derived SMAP29 peptide.It was found to inhibit several antibiotic-resistant bacterial strains.</P><P>Using homology modelling, we obtained the structure of ferritin-ovispirin fusion monomer protein. Using homology alignment, we were able to reconstruct the assembled ferritin-ovispirin monomer into the multimeric star-shaped construct.</P></DIV><DIV class="textbody span"><B>Figure 1:</B> Ferritin-ovispirin-StarCore monomer and assembly obtained by homology modeling.
</DIV><DIV class="textbody h2"><H2>Results</H2></DIV><DIV class="textbody"><P>1.Expression verification</P><P>The ferritin-ovispirin fusion protein was produced via cell-free expression system. The expression was verified by SDS gel as shown in the figure below.</P></DIV><DIV class="textbody span"><B>Figure 2:</B>Cell free expression and purification of Ferritin-ovispirin-StarCore
</DIV><DIV class="textbody"><P>2.MIC and growth curve</P><P>We determined the MIC of ferritin-ovispirin StarCore to inhibit the growth of E coli and B subtilis (figure A and B). We performed growth curve assay for E coli and B subtilis with and without antimicrobial peptides as shown in figure C and D.</P><P>The results indicate that the ferritin-ovispirin StarCore has the MIC activity at 3 ug/ml for both <I>E coli</I> and <I>B subtilis</I>. Moreover, at 7.3 uM it also affects their growth kinetics to a significant extent indicating bactericidal activity. The antibacterial activity of ferritin-ovispirin StarCore is comparable to ovispirin at its MIC concentration (5 uM) alone as shown in the figure.</P></DIV><DIV class="textbody"><P>3. Dynamic time-lapse imaging of bactericidal cell viability</P><P>The following results were obtained by time-lapse microscopy imaging, to study the bactericidal effect of antimicrobial peptides on B subtilis viability. Here we can observe that the presence of antimicrobial peptide proves to be toxic for the growing B subtilis which supports our growth curve data and MIC data.</P></DIV><DIV class="textbody span">
Control
</DIV><DIV class="textbody span">
Ovispirin+Ferritin
</DIV><DIV class="textbody"><P>4. Biocompatibility towards mammalian cell membrane.</P></DIV><DIV class="textbody span"><B>Figure 1.</B> Mammalian liposome leakage induced by ferritin-ovispirin StarCore (A) and the kinetics of liposome leakage (B). Ovispirin (5 uM) and ferritin-ovispirin (3 uM) are used at their MIC concentration obtained from previous results. 
</DIV><DIV class="textbody"><P>To test the biocompatibility of the StarCores with mammalian membrane, we performed liposome leakage assay. Ovispirin alone lyses the liposome indicating damage to mammalian cell membrane. Ferritin-ovispirin has a reduced effect on the liposome leakage indicating an improvement in biocompatibility towards mammalian cell membrane. The Starcore ferritin-ovispirin has a safer profile in terms of membrane activity as compared to ovispirin alone at their respective MIC concentration.</P></DIV><DIV class="textbody h2"><H2>References</H2></DIV><DIV class="textbody"><P>1.Ovispirin obtained from DRAMP database: DRAMP03826</P><P>2.Ferritin obtained from RCSB. PDB number: 4XGS</P><P>3.Star shaped antimicrobial peptides : 10.1038/NMICROBIOL.2016.162</P></DIV><DIV class="textbody h2"><H2>Improved Part - Part: BBa_K2738104 (designed protein lyase cage-enterocin A)</H2></DIV><DIV class="textbody"><P>We aimed to fuse antimicrobial peptides to self-assembling multimeric proteins giving us star-shape antimicrobial peptides called StarCores. The StarCore described here is a result of the fusion of protein-lyase-cage (self-assembling protein) to Enterocin A (antimicrobial peptide) via golden-gate assembly. The fusion protein expression is regulated by T7-promoter.</P><P>The protein-lyase-cage is a multimeric, self-assembling protein formed by synthetically designed monomeric subunits. Enterocin A is an antimicrobial peptide, naturally produced by <I>Enterococcus faecium</I>.</P></DIV><DIV class="textbody h1"><H1>Results</H1></DIV><DIV class="textbody h2"><H2>Expression data</H2></DIV><DIV class="textbody"><P>The lyase-cage-enterocinA fusion protein was produced via cell-free expression system. The expression was verified by SDS gel as shown in the figure below.</P><DIV class="textbody"><P>2. MIC and growth curve</P><P>We determined the MIC of lyase-cage-enterocinA StarCore to inhibit the growth of <I>E. coli</I> and <I>B. subtilis</I> (figure A and B). We performed growth curve assay for <I>E. coli</I> and <I>B. subtilis</I> with and without antimicrobial peptides as shown in figure C and D.</P><P>The results indicate that the lyase-cage-enterocinA StarCore has the MIC activity at 150 ug/ml for <I>B. subtilis</I> but not for <I>E. coli</I>. Moreover, at 7.3 uM it also affects the growth kinetics  <I>B. subtilis</I> to a significant extent indicating bactericidal activity. The antibacterial activity of lyase-cage-enterocinA StarCore is comparable to ovispirin at its MIC concentration (5 uM) alone as shown in the figure.</P></DIV><DIV class="textbody"><P>Biocompatibility towards mammalian cell membrane.</P></DIV><DIV class="textbody span"><B>Figure 2.</B> Mammalian liposome leakage induced by lyase cage-Enterocin A StarCore (A) and the kinetics of liposome leakage (B). Ovispirin (5 uM) and lyase-ovispirin     (3.9 uM) are used at their MIC concentration obtained from previous results.
</DIV><P>Ovispirin alone lyses the liposome indicating damage to mammalian cell membrane. Lyase-cage-enterocin has a reduced effect on the liposome leakage indicating an improvement in biocompatibility towards mammalian cell membrane. The Starcore ferritin-ovispirin has a safer profile in terms of membrane activity as compared to ovispirin alone at their respective MIC concentration.</P></DIV><DIV class="textbody h2"><H2>References</H2></DIV><DIV class="textbody"><P>1.Protein lyase cage obtained from RCSB: 4QCC PDB</P><P>2.Enterocin reference from Bactibase: <A href="http://bactibase.hammamilab.org/BAC088&gt;here&lt;/a&gt;&lt;/br&gt; 
&lt;p&gt;3.Star shaped antimicrobial peptides : &lt;a href=" 10.1038="">here</A></P><P>4.Liposome leakage assay: <A href="https://www.sciencedirect.com/science/article/pii/S007668799778025X">here</A></P></DIV><DIV id="footerdiv"><DIV id="mfooter"><DIV class="footbox"><B>Centre for Research and Interdisciplinarity (CRI)</B>
    Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
    Paris Descartes University
    24, rue du Faubourg Saint Jacques
    75014 Paris, France<A href="mailto:paris-bettencourt-2018@cri-paris.org">paris-bettencourt-2018@cri-paris.org</A></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>